The SINAPPS2 research team based in Oxford is composed of Professor Belinda Lennox, PI; Dr Ksenija Yeeles, project manager; Sally-Anne Vincent, Research Assistant; and Mio Shimazaki, Research Administrator. This group manages PPiP2 and co-manages the SINAPPS2 trial in collaboration with the Cambridge hub. Sally-Anne Vincent supports PPiP2 sites in South West England.
The SINAPPS2 Cambridge trial site is at Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust. The SINAPPS2 trial team, which includes Professor Alasdair Coles and Giuliano Tomei, Research Assistant, co-manages the SINAPPS studies in collaboration with the Oxford hub, and liaises with the local mental health NHS services recruiting for PPiP2 in East of England and Midlands.
SINAPPS2 hub in London consist of two sites (University College London Hospital NHS Foundation Trust (Dr Michael Zandi, PI, Prof Eileen Joyce, Co-PI) and King’s College Hospital NHS Foundation Trust, (Dr Nick Moran, PI). Research Assistant Rebecca Pollard assists at both London sites in running of the trial and supporting local researchers in all PPiP2 sites in London and Kent .
The SINAPPS2 Nottingham trial site is based at Queen's Medical Centre, Nottingham University Hospitals NHS Foundation Trust. The local SINAPPS2 team consists of Dr Akram Hosseini (PI), Dr Benjamin Lomas and is supported by Giuliano Tomei in the delivery of the study.
Members of the Trial Management Group (TMG) are Professor Alasdair Coles (CI), University of Cambridge; Professor Belinda Lennox (PI, Oxford ) University of Oxford; Professor Peter Jones, University of Cambridge; Dr Michael Zandi, University College London Hospitals NHS Trust; Professor Ly-Mee Yu, University of Oxford; Dr Francis Dowling, Trial Coordinator, Cambridge Clinical Trial Unit; Dr Ksenija Yeeles, Project Manager, University of Oxford.